Contact

 
Epizyme was recently acquired by Ipsen. To find out more, visit Ipsen.com.

Clinical Trial Information
Toll free in the U.S.: (855) 500-1011
clinicaltrials@epizyme.com

Epizyme Medical Information
Toll-free in the U.S.: 1-866-4EPZMED
medinfo@epizyme.com

Product-Related Information
1-833-4EPINOW (1-833-437-4669)

To report an adverse event or product complaint:
Toll-free in the U.S.:
1-866-4EPZMED (1-866-437-9633)

For Ipsen related product questions:
Phone: 1-855-463-5127
Fax: 1-855-631-0644

Business Development Inquiries
bd@epizyme.com

Media Inquiries
Joanna Parish, Global Head of Franchise Communications Oncology, Ipsen Global Oncology Franchise
+44 7840 023 741

Ioana Piscociu, Senior Manager, Ipsen Global Media Relations
+33 6 69 09 12 96

Investors Inquiries
Craig Marks, Vice President, Ipsen Global Investor Relations
+44 7584 349 193

Adrien Dupin de Saint-Cyr, Investor Relations Manager, Ipsen Global Investor Relations
+33 6 64 26 17 49

Epizyme, Inc.
400 Technology Square, 4th Floor
Cambridge, MA 02139
Phone: (617) 229-5872
Fax: (617) 349-0707
contact@epizyme.com
 
We are collecting personal information in order to fulfill your request. Please see Epizyme’s privacy policy here.